- Home
- Applications
- diabetes mellitus
Refine by
Diabetes Mellitus Product Applications
6 applications found
Sitagliptin is an dipeptidyl peptidase-4 (DPP-4) inhibitor for treatment of diabetes mellitus type 2. ...
ByBOC Sciences based in Shirley, NEW YORK (USA)
Indeed, The EMR software is the best one for the diabetologist practice as it is useful for designing diabetes-specific templates and assisting in the tracking of blood glucose levels immediately from the patient’s admission to the hospital. ...
ByHealthray Technologies PTV. Ltd. based in Surat, INDIA
MR Elastography (MRE) measures stiffness by assessing four images across the entire liver, resulting in a comprehensive and incredibly accurate diagnosis not available with other non-invasive technologies. In addition to a stiffness score measured in kPa, clinicians and patients often receive color-coded maps of their liver fibrosis, called Elastograms. In these intuitive maps, red corresponds to highly advanced fibrosis, while purple represents healthy liver ...
ByResoundant, Inc. based in Rochester, MINNESOTA (USA)
Aortic pulse wave velocity (PWVao) is a powerful independent predictor of mortality in both Diabetes and glucose intolerance test population samples. In displacing systolic blood pressure as a prognostic factor, aortic pulse wave velocity represents a useful integrated index of vascular status and hence cardiovascular diseases. Considering the Diabetes as a vascular disease, the measurement of the aortic stiffness plays an extremely important role in evaluation of the special cardiovascular risk ...
ByTensiomed based in Budapest, HUNGARY
Our flagship products, Virtue SAB and BackBeat CNT, have the potential to improve clinical outcomes and provide distinct commercial advantages within two of the largest and most well-established global medical device ...
ByOrchestra BioMed, Inc. based in New Hope, PENNSYLVANIA (USA)
The CV risk assessment and the hypertension management are ones of the most common activities by the cardiologists. The measurement of arterial stiffness provides a strong and independent marker to reveal high CV risk even among those subjects, whose traditional risk factors based CV risk scores provide normal or only intermediate risk. It is a well known fact that there is a significant difference between the anti-hypertensive drugs concerning their lowering efficacy of central blood pressure and the arterial ...
ByTensiomed based in Budapest, HUNGARY